Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-07 09:16 am Purchase | 2026-06-30 | 13G | CORVUS PHARMACEUTICALS INC CRVS | STATE STREET CORP STT | 4,474,091 5.300% | 4,474,091 (New Position) | Filing History |
| 2026-07-27 4:25 pm Purchase | 2026-06-30 | 13G | CORVUS PHARMACEUTICALS INC CRVS | BlackRock Inc. BLK | 6,325,157 7.500% | 937,339 (+17.40%) | Filing History |
| 2026-05-15 4:13 pm Sale | 2026-03-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Point72 Asset Management, L.P. | 0 0.000% | -17,050,384 (Position Closed) | Filing History |
| 2026-05-15 08:11 am Purchase | 2026-03-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Sirenia Capital Management LP | 6,831,828 7.500% | 6,831,828 (New Position) | Filing History |
| 2026-04-27 4:12 pm Purchase | 2026-03-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | BlackRock Inc. BLK | 5,387,818 6.400% | 1,372,308 (+34.18%) | Filing History |
| 2026-03-26 5:39 pm Sale | 2026-03-13 | 13G | CORVUS PHARMACEUTICALS INC CRVS | VANGUARD GROUP INC | 0 0.000% | -3,873,482 (Position Closed) | Filing History |
| 2026-02-13 4:31 pm Purchase | 2025-12-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | MILLER RICHARD A MD | 6,085,922 7.800% | 865,554 (+16.58%) | Filing History |
| 2026-02-05 10:29 am Unchanged | 2026-01-23 | 13D | CORVUS PHARMACEUTICALS INC CRVS | ADAMS STREET PARTNERS LLC | 3,275,616 3.900% | 0 (Unchanged) | Filing History |
| 2026-01-30 1:26 pm Purchase | 2025-12-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | VANGUARD GROUP INC | 3,873,482 5.180% | 3,873,482 (New Position) | Filing History |
| 2026-01-27 8:38 pm Sale | 2026-01-23 | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 8,609,091 10.300% | -1,176,332 (-12.02%) | Filing History |
| 2025-10-17 6:40 pm Purchase | 2025-09-30 | 13G | CORVUS PHARMACEUTICALS INC CRVS | BlackRock Inc. BLK | 4,015,510 5.400% | 4,015,510 (New Position) | Filing History |
| 2025-08-14 1:32 pm Sale | 2025-06-30 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Samlyn Capital, LLC | 0 0.000% | -4,065,935 (Position Closed) | Filing History |
| 2025-05-15 3:34 pm Sale | 2025-03-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Samlyn Capital, LLC | 4,065,935 6.000% | -2,601,170 (-39.01%) | Filing History |
| 2025-05-14 8:49 pm Unchanged | 2025-05-12 | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 9,785,423 12.200% | 0 (Unchanged) | Filing History |
| 2025-05-01 9:20 pm Purchase | 2025-04-29 | 13D | CORVUS PHARMACEUTICALS INC CRVS | ORBIMED ADVISORS LLC | 9,785,423 13.800% | 2,841,769 (+40.93%) | Filing History |
| 2025-02-14 1:53 pm Purchase | 2024-12-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Samlyn Capital, LLC | 6,667,105 9.800% | 403,347 (+6.44%) | Filing History |
| 2025-02-13 4:30 pm Purchase | 2024-12-31 | 13G | CORVUS PHARMACEUTICALS INC CRVS | MILLER RICHARD A MD | 5,220,368 7.700% | 1,536,358 (+41.70%) | Filing History |
| 2024-08-01 9:18 pm Sale | 2024-08-01 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Samlyn Capital, LLC | 6,263,758 9.990% | -4,226 (-0.07%) | Filing History |
| 2024-05-13 4:52 pm Purchase | 2024-05-01 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Samlyn Capital, LLC | 6,267,984 9.990% | 3,771,725 (+151.10%) | Filing History |
| 2024-05-09 5:29 pm Purchase | 2024-05-02 | 13G | CORVUS PHARMACEUTICALS INC CRVS | Point72 Asset Management, L.P. | 17,050,384 9.900% | 17,050,384 (New Position) | Filing History |